No results for ‘’
Glenmark Pharmaceuticals Ltd
₹2209.60
(1.52%)
Wed, 17 Jun 2026, 05:22 pm
Health Technology
Pharmaceuticals: Major
24.5KGlenmark Pharmaceuticals Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2232.10 | 2193.20 | 2175.60 | 2154.30 | 2136.70 | 2115.40 | 2076.50 |
| Fibonacci | 2193.20 | 2178.34 | 2169.16 | 2154.30 | 2139.44 | 2130.26 | 2115.40 |
| Camarilla | 2168.70 | 2165.13 | 2161.57 | 2154.30 | 2154.43 | 2150.87 | 2147.30 |
Pivots Level: Classic
R3
+77.80
2232.10
R2
+38.90
2193.20
R1
+21.30
2175.60
S1
-17.60
2136.70
S2
-38.90
2115.40
S3
-77.80
2076.50
Pivots Level: camarilla
R3
+14.40
2168.70
R2
+10.83
2165.13
R1
+7.27
2161.57
S1
-0.13
2154.43
S2
-3.43
2150.87
S3
-7.00
2147.30
Moving Average
Period
Value
10-EMA
2135.12
20-EMA
2137.17
30-EMA
2139.52
50-EMA
2143.38
100-EMA
2151.04
200-EMA
2167.32
Technical Indicators
Period
Value
ADX
29.36
ADX+DI
19.27
ADX+DI[1]
19.32
ADX-DI
27.13
ADX-DI[1]
28.61
AO
-8.24
AO[1]
-9.36
AO[2]
-10.30
BBPower
3.97
CCI20
39.99
CCI20[1]
-10.41
HullMA9
2136.44
Ichimoku.BLine
2135.75
MACD.macd
-3.22
MACD.signal
-4.01
Mom
3.50
Mom[1]
-1.40
RSI
51.43
RSI[1]
44.95
Rec.BBPower
0
Rec.HullMA9
1
Rec.Ichimoku
0
Rec.Stoch.RSI
0
Rec.UO
0
Rec.VWMA
1
Rec.WR
0
Recommend.All
0.09
Recommend.MA
0
Recommend.Other
0.18
Stoch.D
33.28
Stoch.D[1]
37.19
Stoch.K
47.36
Stoch.K[1]
57.17
Stoch.RSI.K
84.39
UO
54.82
VWMA
2136.63
W.R
-37.13
close
2139.90
Glenmark Pharmaceuticals Ltd Technical Analysis
Glenmark Pharmaceuticals Ltd technical analysis is gaining attention among traders and investors tracking Glenmark Pharmaceuticals Ltd Technical Analysis trends in the Indian stock market. Glenmark Pharmaceuticals Ltd (NSE: GLENMARK, BSE: 532296) is currently trading at ₹2209.60, showing a 1.52% move as of Wed, Jun 17, 2026.
This detailed Glenmark Pharmaceuticals Ltd technical analysis covers support & resistance levels, moving averages, indicators, and overall market sentiment to help investors make informed decisions.
Glenmark Pharmaceuticals Ltd Stock Overview
Glenmark Pharmaceuticals Ltd operates in the Health technology sector under the Pharmaceuticals: major industry. With a market capitalization of ₹61478.86Cr and a PE ratio of 45.80, Glenmark Pharmaceuticals Ltd remains a key stock to watch in Glenmark Pharmaceuticals Ltd Technical Analysis searches.
Key Metrics
- Market Cap: ₹61478.86Cr
- PE Ratio: 45.80
- Dividend Yield: 0.23
- Sector: Health technology
- Industry: Pharmaceuticals: major
These fundamentals play an important role in Glenmark Pharmaceuticals Ltd technical analysis and valuation tracking.
Glenmark Pharmaceuticals Ltd Support and Resistance Levels
Classic Pivot Levels
In Glenmark Pharmaceuticals Ltd technical analysis, pivot levels help identify potential reversal and breakout zones.
- Resistance 3: 2741.13
- Resistance 2: 2527.43
- Resistance 1: 2401.17
- Pivot Point: 2313.73
- Support 1: 2187.47
- Support 2: 2100.03
- Support 3: 1886.33
Conditional Insight
Glenmark Pharmaceuticals Ltd technical analysis suggests a bearish to neutral trend as the price is below the pivot point. Immediate support is seen near 2187.47 and 2100.03.
Fibonacci Levels Analysis
Fibonacci levels are widely used in Glenmark Pharmaceuticals Ltd technical analysis to identify retracement zones.
- Fibonacci R3: 2527.43
- Fibonacci R2: 2445.80
- Fibonacci R1: 2395.37
- Fibonacci Pivot: 2313.73
- Fibonacci S1: 2232.10
- Fibonacci S2: 2181.67
- Fibonacci S3: 2100.03
Glenmark Pharmaceuticals Ltd technical analysis indicates consolidation between Fibonacci pivot and resistance zones.
Glenmark Pharmaceuticals Ltd Moving Average Analysis
Moving averages are key indicators in Glenmark Pharmaceuticals Ltd technical analysis for identifying trend direction.
- 10 EMA: 2172.69
- 20 EMA: 2209.58
- 30 EMA: 2227.31
- 50 EMA: 2227.25
- 100 EMA: 2176.56
- 200 EMA: 2064.72
Trend Logic
Glenmark Pharmaceuticals Ltd technical analysis indicates bearish pressure, with price trading below key moving averages.
Long-term trend in Glenmark Pharmaceuticals Ltd technical analysis remains positive above 200 EMA.
Glenmark Pharmaceuticals Ltd Technical Indicators Overview
Momentum Indicators
- RSI: 38.78
- MACD: -41.14
- Signal: -32.59
- ADX: 26.58
- Momentum: -37.40
RSI Logic
Glenmark Pharmaceuticals Ltd technical analysis shows RSI in neutral range, suggesting consolidation.
MACD Logic
Glenmark Pharmaceuticals Ltd technical analysis indicates bearish momentum with MACD below signal line.
Glenmark Pharmaceuticals Ltd Overall Recommendation
- Overall Recommendation Score: -0.47
- Moving Average Recommendation: -0.67
- Other Indicators Recommendation: -0.27
Overall Glenmark Pharmaceuticals Ltd technical analysis sentiment remains neutral with mixed signals.
Glenmark Pharmaceuticals Ltd Technical Analysis Conclusion
Glenmark Pharmaceuticals Ltd technical analysis suggests that traders should closely monitor price action around ₹2209.60 and key pivot level 2313.73. Breakouts above resistance or breakdown below support will define the next trend in Glenmark Pharmaceuticals Ltd technical analysis.
Investors searching for Glenmark Pharmaceuticals Ltd Technical Analysis should track moving averages, RSI levels, and volume trends to identify potential entry and exit opportunities. As market conditions change, Glenmark Pharmaceuticals Ltd technical analysis will continue to play a crucial role in short-term trading and long-term investment strategies.